Initial Oral Vinorelbine Dosing Schedules in Clinical Routine in Germany and Austria

Conditions

• Non-Small-Cell Lung Cancer
• Breast Cancer

Interventions

• DRUG: Vinorelbine oral

Sponsor

Pierre Fabre Pharma GmbH

Collaborators

• [object Object]